Lipocine Inc

NASDAQ:LPCN   2:42:44 PM EDT
0.33
+0.01 (+2.69%)
Products

Lipocine Says U.S. FDA HAS GRANTED TENTATIVE APPROVAL TO TLANDO

Published: 12/09/2020 01:59 GMT
Lipocine Inc (LPCN) - Lipocine Announces Tentative Approval of Tlando™.
U.S. Food and Drug Administration ("fda") Has Granted Tentative Approval to Tlando.
Tlando is Not Eligible for Final Approval and Marketing in U.S.